Skip to main content
Equibles
XNCR logo

XNCR · Xencor Inc · Metrics

Track XNCR — free

Use XNCR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XNCR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$24.85 +1.66 (+7.16%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.84B
Shares
74.35M
Volume · Oct 20 376.93K Avg daily vol (3M) 1.37M

XNCR metrics

88 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$23.19
Market cap
$1.84B

Price action

20 metrics
Price change (1W)
-7.4%
Price change (30D)
-7.4%
Price change (3M)
+23.3%
Price change (6M)
+81.2%
Price change (YTD)
+51.5%
Price change (1Y)
+57.0%
Trailing year
Price change (5Y)
-39.1%
52-week high
$29.30
52-week low
$10.41
Change from 52-week high
-20.9%
Change from 52-week low
+122.8%
Annualized volatility
63.8%
Annualized volatility (3M)
60.5%
Beta
1.2
RSI (14D)
42.7
Price vs SMA 50
-7.5%
Price vs SMA 200
+41.8%
Avg volume (3M)
1.37M
Relative volume
1.5
Average dollar volume
$33.13M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
74.35M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
16.4×
reciprocal yield 6.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
15.8×
reciprocal yield 6.3%
P / book
3.3
reciprocal yield 30.3%
FCF yield
-12.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.8%

Historical valuation

8 metrics
P / E historical average (3Y)
53.6×
reciprocal yield 1.9%
P / E historical average (5Y)
53.6×
reciprocal yield 1.9%
EV / revenue historical average (3Y)
6.1×
reciprocal yield 16.5%
EV / revenue historical average (5Y)
6.5×
reciprocal yield 15.3%
EV / EBIT historical average (3Y)
38.1×
reciprocal yield 2.6%
EV / EBIT historical average (5Y)
38.1×
reciprocal yield 2.6%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-26
Last earnings
2026-05-05

Profitability

9 metrics
Gross margin
—
Operating margin
-205.8%
Trailing 12 months
Net margin
-155.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$216.08M
Net income (TTM)
−$163.11M
Trailing 12 months
Diluted EPS (TTM)
$-2.17
FCF margin
-198.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.40
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-2.88
EBITDA per diluted share (TTM)
$-2.74
Net income per diluted share (TTM)
$-2.17
Operating cash flow per diluted share (TTM)
$-2.74
Free cash flow per diluted share (TTM)
$-2.77
Capital expenditures per diluted share (TTM)
$0.03
R&D per diluted share (TTM)
$3.41
Stock compensation per diluted share (TTM)
$0.52
Book value per share
$8.84

Growth

11 metrics
Revenue growth YoY
+17.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$104.97M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.1%
Year over year · more shares
Revenue CAGR (3Y)
-8.6%
Revenue CAGR (5Y)
+0.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-32.4%
Return on assets
-22.5%
Debt / equity
0.2
Current ratio
6.4
EBITDA (TTM)
−$205.79M
Free cash flow (TTM)
−$208.28M
Quick ratio
6.4
Interest coverage
-8.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$60.23M
Latest balance sheet
Cash & equivalents
$44.66M
Total assets
$724.96M
Total debt
$104.89M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$205.81M
Capital expenditures (TTM)
$2.47M
R&D (TTM)
$255.76M
SG&A (TTM)
—
Stock compensation (TTM)
$39.03M
R&D / revenue
243.6%
Stock compensation / revenue
37.2%

Ownership (13F)

9 metrics
13F filers
208
13F filer change QoQ
+5
Institutional ownership
113.2%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-4.7%
Holder tenure
14.1
Price vs estimated holder cost
+5.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
27.2%

Short interest

3 metrics
Short interest
22.0%
Latest settlement · 10.1 days to cover
Days to cover
10.1d
Short-squeeze score
92 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1326732 CUSIP 98401F105 13F (30d) 22 filings 22 filers Visit website Investor relations